Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Screening and Decolonization to Reduce Surgical Site Infection in Elective Total Joint Arthroplasty

Journal of Arthroplasty

Volumn 31, Issue 9, 2016, Pages 144-147

  Sporer, Scott M ^a,b   Rogers, Thea ^a   Abella, Linda ^a  

^a CENTRAL DUPAGE HOSPITAL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

arthroplasty; complication; infection; nasal screening; staphylococcus; surgical site

Indexed keywords

CEFAZOLIN; CHLORHEXIDINE GLUCONATE; PSEUDOMONIC ACID; VANCOMYCIN; CHLORHEXIDINE; METICILLIN; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ANTISEPSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL PROTOCOL; CLOTHING; COHORT ANALYSIS; CONTROLLED STUDY; DECOLONIZATION; FEMALE; HUMAN; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; NOSE SMEAR; PEROPERATIVE COMPLICATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE ARTHROPLASTY; ANALOGS AND DERIVATIVES; ARTHROPLASTY; CLINICAL TRIAL; ELECTIVE SURGERY; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOSE CAVITY; PENICILLIN RESISTANCE; PREOPERATIVE CARE; REPLACEMENT ARTHROPLASTY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

ADMINISTRATION, INTRANASAL; AGED; ANTI-INFECTIVE AGENTS, LOCAL; ARTHROPLASTY; ARTHROPLASTY, REPLACEMENT; CHLORHEXIDINE; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MUPIROCIN; NASAL CAVITY; PREOPERATIVE CARE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 84992500330     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.05.019     Document Type: Article

References (7)

1. 1 Bozic, K.J., Lau, E., Kurtz, S., et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am, 94(9), 2012, 794.
2. 2 Laudermilch, D.J., Fedorka, C.J., Heyl, A., et al. Outcomes of revision total knee arthroplasty after methicillin-resistant Staphylococcus aureus infection. Clin Orthop Relat Res, 468(8), 2010, 2067.
3. 3 Kurtz, S.M., Lau, E., Watson, H., et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty, 27(8 Suppl), 2012, 61.
4. 4 Kluytmans, J., van Belkum, A., Verbrugh, H., Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev, 10(3), 1997, 505.
5. 5 Tacconelli, E., Carmeli, Y., Aizer, A., et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis, 37(12), 2003, 1629.
6. 6 Kim, D.H., Spencer, M., Davidson, S.M., et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am, 92(9), 2010, 1820.
7. 7 Rao, N., Cannella, B.A., Crossett, L.S., et al. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection: prospective cohort study with 2-year follow-up. J Arthroplasty, 26(8), 2011, 1501.